Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photopheresis in erythrodermic mycosis fungoides and Sézary syndrome
NCT03563040Phase 2Withdrawn
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Dec 2020
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
A Phase 2 trial of methoxsalen in mycosis fungoides (MF), Sézary syndrome (SS), sponsored by European Organisation for Research and Treatment of Cancer. Planned start Dec 2020; status: withdrawn.
02
Drugs
methoxsalen
03
Conditions
mycosis fungoides (MF)Sézary syndrome (SS)
Beyond the preview
Go deeper on NCT03563040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03563040.